Stock futures were flat to slightly weaker on Sunday evening, as investors weighed new COVID-19 infections — which are leading to rising deaths and a record number of hospitalizations across the U.S. — against the rapidly unfolding timetable for the deployment of a vaccine.
Investors have been broadly encouraged by the steady flow of positive news over a coronavirus cure. Pfizer (PFE) and BioNTech (BNTX) said on Friday they plan to file for an emergency use authorization with the U.S….
Source link
